COMPASS Pathways (CMPS)
(Delayed Data from NSDQ)
$6.84 USD
+0.45 (7.04%)
Updated Jun 12, 2024 04:00 PM ET
After-Market: $6.82 -0.02 (-0.29%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Brokerage Reports
COMPASS Pathways PLC Sponsored ADR [CMPS]
Reports for Purchase
Showing records 41 - 60 ( 83 total )
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Positive Data Emerges From Independent Psilocybin Studies in Treatment-Resistant Depression and Anorexia; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Bicycle Day: Honoring the Chemist Who Opened the Door
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Conference Takeaways: Psychedelic Panel Discussion
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
4Q21 Results; FDA Meeting, Potential R&D Day Event in 2Q22 Represent Key Potential Near-Term Positive Events
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Biotechnology Breakthrough Innovation? Rubbish
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Psychedelic Medicine Panel Discussion at the Annual ROTH Conference
Provider: Roth Capital Partners, Inc.
Analyst: PIROS E
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Psychedelic Medicine Companies are Building the Largest Pharmaceutical Market
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Unexpected Positive Data for COMP360 Plus SSRI Therapy in Depression
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Attractive Entry Point Ahead of Multiple Potential Positive Events in 2022
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Psychedelics Space Poised for Breakout Year in 2022
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P